nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—CYP2C9—Estropipate—osteoporosis	0.0681	0.102	CbGbCtD
Trimethoprim—CYP2C8—Raloxifene—osteoporosis	0.0651	0.0972	CbGbCtD
Trimethoprim—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0629	0.0939	CbGbCtD
Trimethoprim—CYP2C8—Cholecalciferol—osteoporosis	0.0503	0.0751	CbGbCtD
Trimethoprim—ABCB1—Ethinyl Estradiol—osteoporosis	0.0426	0.0636	CbGbCtD
Trimethoprim—CYP2C8—Estradiol—osteoporosis	0.0405	0.0605	CbGbCtD
Trimethoprim—CYP3A4—Estropipate—osteoporosis	0.0396	0.0591	CbGbCtD
Trimethoprim—CYP3A4—Calcitriol—osteoporosis	0.0396	0.0591	CbGbCtD
Trimethoprim—CYP2C9—Cholecalciferol—osteoporosis	0.0351	0.0524	CbGbCtD
Trimethoprim—CYP3A4—Ergocalciferol—osteoporosis	0.0316	0.0472	CbGbCtD
Trimethoprim—ABCB1—Conjugated Estrogens—osteoporosis	0.0312	0.0467	CbGbCtD
Trimethoprim—CYP2C9—Estradiol—osteoporosis	0.0283	0.0422	CbGbCtD
Trimethoprim—ABCB1—Estradiol—osteoporosis	0.0274	0.041	CbGbCtD
Trimethoprim—CYP3A4—Raloxifene—osteoporosis	0.0264	0.0394	CbGbCtD
Trimethoprim—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0255	0.0381	CbGbCtD
Trimethoprim—CYP3A4—Cholecalciferol—osteoporosis	0.0204	0.0304	CbGbCtD
Trimethoprim—CYP3A4—Conjugated Estrogens—osteoporosis	0.0187	0.028	CbGbCtD
Trimethoprim—CYP3A4—Estradiol—osteoporosis	0.0164	0.0245	CbGbCtD
Trimethoprim—TYMS—Levorphanol—Estradiol—osteoporosis	0.00154	0.469	CbGdCrCtD
Trimethoprim—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.00102	0.31	CbGdCrCtD
Trimethoprim—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00073	0.222	CbGdCrCtD
Trimethoprim—Arthralgia—Pamidronate—osteoporosis	0.000378	0.00143	CcSEcCtD
Trimethoprim—Myalgia—Pamidronate—osteoporosis	0.000378	0.00143	CcSEcCtD
Trimethoprim—Urticaria—Alendronate—osteoporosis	0.000378	0.00142	CcSEcCtD
Trimethoprim—Epistaxis—Estradiol—osteoporosis	0.000377	0.00142	CcSEcCtD
Trimethoprim—Anxiety—Pamidronate—osteoporosis	0.000377	0.00142	CcSEcCtD
Trimethoprim—Abdominal pain—Alendronate—osteoporosis	0.000376	0.00142	CcSEcCtD
Trimethoprim—Body temperature increased—Alendronate—osteoporosis	0.000376	0.00142	CcSEcCtD
Trimethoprim—Shock—Risedronate—osteoporosis	0.000375	0.00142	CcSEcCtD
Trimethoprim—Nervous system disorder—Risedronate—osteoporosis	0.000374	0.00141	CcSEcCtD
Trimethoprim—Agitation—Zoledronate—osteoporosis	0.000373	0.00141	CcSEcCtD
Trimethoprim—Angioedema—Zoledronate—osteoporosis	0.000371	0.0014	CcSEcCtD
Trimethoprim—Skin disorder—Risedronate—osteoporosis	0.00037	0.0014	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Calcitriol—osteoporosis	0.00037	0.0014	CcSEcCtD
Trimethoprim—Abdominal pain—Raloxifene—osteoporosis	0.00037	0.00139	CcSEcCtD
Trimethoprim—Body temperature increased—Raloxifene—osteoporosis	0.00037	0.00139	CcSEcCtD
Trimethoprim—Urticaria—Ibandronate—osteoporosis	0.000368	0.00139	CcSEcCtD
Trimethoprim—Abdominal pain—Ibandronate—osteoporosis	0.000366	0.00138	CcSEcCtD
Trimethoprim—Body temperature increased—Ibandronate—osteoporosis	0.000366	0.00138	CcSEcCtD
Trimethoprim—Confusional state—Pamidronate—osteoporosis	0.000366	0.00138	CcSEcCtD
Trimethoprim—Vertigo—Zoledronate—osteoporosis	0.000365	0.00138	CcSEcCtD
Trimethoprim—Syncope—Zoledronate—osteoporosis	0.000364	0.00137	CcSEcCtD
Trimethoprim—Leukopenia—Zoledronate—osteoporosis	0.000363	0.00137	CcSEcCtD
Trimethoprim—Anaphylactic shock—Pamidronate—osteoporosis	0.000363	0.00137	CcSEcCtD
Trimethoprim—Urticaria—Calcitriol—osteoporosis	0.00036	0.00136	CcSEcCtD
Trimethoprim—Body temperature increased—Calcitriol—osteoporosis	0.000358	0.00135	CcSEcCtD
Trimethoprim—Abdominal pain—Calcitriol—osteoporosis	0.000358	0.00135	CcSEcCtD
Trimethoprim—Angioedema—Conjugated Estrogens—osteoporosis	0.000357	0.00135	CcSEcCtD
Trimethoprim—Shock—Pamidronate—osteoporosis	0.000357	0.00135	CcSEcCtD
Trimethoprim—Loss of consciousness—Zoledronate—osteoporosis	0.000357	0.00135	CcSEcCtD
Trimethoprim—Hypersensitivity—Estropipate—osteoporosis	0.000356	0.00134	CcSEcCtD
Trimethoprim—Nervous system disorder—Pamidronate—osteoporosis	0.000356	0.00134	CcSEcCtD
Trimethoprim—Thrombocytopenia—Pamidronate—osteoporosis	0.000355	0.00134	CcSEcCtD
Trimethoprim—Urinary tract disorder—Estradiol—osteoporosis	0.000355	0.00134	CcSEcCtD
Trimethoprim—Vomiting—Etidronic acid—osteoporosis	0.000355	0.00134	CcSEcCtD
Trimethoprim—Cough—Zoledronate—osteoporosis	0.000354	0.00134	CcSEcCtD
Trimethoprim—Connective tissue disorder—Estradiol—osteoporosis	0.000353	0.00133	CcSEcCtD
Trimethoprim—Urethral disorder—Estradiol—osteoporosis	0.000352	0.00133	CcSEcCtD
Trimethoprim—Rash—Etidronic acid—osteoporosis	0.000352	0.00133	CcSEcCtD
Trimethoprim—Convulsion—Zoledronate—osteoporosis	0.000352	0.00133	CcSEcCtD
Trimethoprim—Dermatitis—Etidronic acid—osteoporosis	0.000351	0.00133	CcSEcCtD
Trimethoprim—Vertigo—Conjugated Estrogens—osteoporosis	0.000351	0.00132	CcSEcCtD
Trimethoprim—Syncope—Conjugated Estrogens—osteoporosis	0.00035	0.00132	CcSEcCtD
Trimethoprim—Hypersensitivity—Alendronate—osteoporosis	0.00035	0.00132	CcSEcCtD
Trimethoprim—Headache—Etidronic acid—osteoporosis	0.000349	0.00132	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000348	0.00131	CcSEcCtD
Trimethoprim—Anorexia—Pamidronate—osteoporosis	0.000346	0.0013	CcSEcCtD
Trimethoprim—Arthralgia—Zoledronate—osteoporosis	0.000345	0.0013	CcSEcCtD
Trimethoprim—Myalgia—Zoledronate—osteoporosis	0.000345	0.0013	CcSEcCtD
Trimethoprim—Insomnia—Risedronate—osteoporosis	0.000345	0.0013	CcSEcCtD
Trimethoprim—Anxiety—Zoledronate—osteoporosis	0.000344	0.0013	CcSEcCtD
Trimethoprim—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000343	0.0013	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000343	0.00129	CcSEcCtD
Trimethoprim—Pruritus—Estropipate—osteoporosis	0.000341	0.00129	CcSEcCtD
Trimethoprim—Hypersensitivity—Ibandronate—osteoporosis	0.000341	0.00129	CcSEcCtD
Trimethoprim—Cough—Conjugated Estrogens—osteoporosis	0.000341	0.00129	CcSEcCtD
Trimethoprim—Dyspnoea—Risedronate—osteoporosis	0.00034	0.00128	CcSEcCtD
Trimethoprim—Erythema multiforme—Estradiol—osteoporosis	0.00034	0.00128	CcSEcCtD
Trimethoprim—Convulsion—Conjugated Estrogens—osteoporosis	0.000339	0.00128	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000338	0.00127	CcSEcCtD
Trimethoprim—Pruritus—Alendronate—osteoporosis	0.000336	0.00127	CcSEcCtD
Trimethoprim—Dyspepsia—Risedronate—osteoporosis	0.000336	0.00127	CcSEcCtD
Trimethoprim—Eye disorder—Estradiol—osteoporosis	0.000336	0.00127	CcSEcCtD
Trimethoprim—Tinnitus—Estradiol—osteoporosis	0.000335	0.00126	CcSEcCtD
Trimethoprim—Constipation—Ethinyl Estradiol—osteoporosis	0.000335	0.00126	CcSEcCtD
Trimethoprim—Confusional state—Zoledronate—osteoporosis	0.000334	0.00126	CcSEcCtD
Trimethoprim—Hypersensitivity—Calcitriol—osteoporosis	0.000334	0.00126	CcSEcCtD
Trimethoprim—Myalgia—Conjugated Estrogens—osteoporosis	0.000333	0.00125	CcSEcCtD
Trimethoprim—Arthralgia—Conjugated Estrogens—osteoporosis	0.000333	0.00125	CcSEcCtD
Trimethoprim—Anxiety—Conjugated Estrogens—osteoporosis	0.000332	0.00125	CcSEcCtD
Trimethoprim—Nausea—Etidronic acid—osteoporosis	0.000331	0.00125	CcSEcCtD
Trimethoprim—Anaphylactic shock—Zoledronate—osteoporosis	0.000331	0.00125	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00033	0.00125	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00033	0.00125	CcSEcCtD
Trimethoprim—Diarrhoea—Estropipate—osteoporosis	0.00033	0.00125	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Risedronate—osteoporosis	0.000329	0.00124	CcSEcCtD
Trimethoprim—Insomnia—Pamidronate—osteoporosis	0.000328	0.00124	CcSEcCtD
Trimethoprim—Pruritus—Ibandronate—osteoporosis	0.000327	0.00123	CcSEcCtD
Trimethoprim—Constipation—Risedronate—osteoporosis	0.000326	0.00123	CcSEcCtD
Trimethoprim—Shock—Zoledronate—osteoporosis	0.000326	0.00123	CcSEcCtD
Trimethoprim—Diarrhoea—Alendronate—osteoporosis	0.000325	0.00123	CcSEcCtD
Trimethoprim—Nervous system disorder—Zoledronate—osteoporosis	0.000325	0.00122	CcSEcCtD
Trimethoprim—Immune system disorder—Estradiol—osteoporosis	0.000324	0.00122	CcSEcCtD
Trimethoprim—Thrombocytopenia—Zoledronate—osteoporosis	0.000324	0.00122	CcSEcCtD
Trimethoprim—Mediastinal disorder—Estradiol—osteoporosis	0.000324	0.00122	CcSEcCtD
Trimethoprim—Dyspnoea—Pamidronate—osteoporosis	0.000323	0.00122	CcSEcCtD
Trimethoprim—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000322	0.00122	CcSEcCtD
Trimethoprim—Skin disorder—Zoledronate—osteoporosis	0.000322	0.00121	CcSEcCtD
Trimethoprim—Pruritus—Calcitriol—osteoporosis	0.000321	0.00121	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00032	0.00121	CcSEcCtD
Trimethoprim—Diarrhoea—Raloxifene—osteoporosis	0.00032	0.00121	CcSEcCtD
Trimethoprim—Dyspepsia—Pamidronate—osteoporosis	0.000319	0.0012	CcSEcCtD
Trimethoprim—Dizziness—Estropipate—osteoporosis	0.000319	0.0012	CcSEcCtD
Trimethoprim—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000319	0.0012	CcSEcCtD
Trimethoprim—Diarrhoea—Ibandronate—osteoporosis	0.000317	0.00119	CcSEcCtD
Trimethoprim—Anorexia—Zoledronate—osteoporosis	0.000316	0.00119	CcSEcCtD
Trimethoprim—Decreased appetite—Pamidronate—osteoporosis	0.000315	0.00119	CcSEcCtD
Trimethoprim—Mental disorder—Estradiol—osteoporosis	0.000315	0.00119	CcSEcCtD
Trimethoprim—Dizziness—Alendronate—osteoporosis	0.000314	0.00119	CcSEcCtD
Trimethoprim—Shock—Conjugated Estrogens—osteoporosis	0.000314	0.00118	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000313	0.00118	CcSEcCtD
Trimethoprim—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000313	0.00118	CcSEcCtD
Trimethoprim—Malnutrition—Estradiol—osteoporosis	0.000313	0.00118	CcSEcCtD
Trimethoprim—Erythema—Estradiol—osteoporosis	0.000313	0.00118	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Risedronate—osteoporosis	0.000312	0.00118	CcSEcCtD
Trimethoprim—Urticaria—Ethinyl Estradiol—osteoporosis	0.000311	0.00117	CcSEcCtD
Trimethoprim—Constipation—Pamidronate—osteoporosis	0.00031	0.00117	CcSEcCtD
Trimethoprim—Diarrhoea—Calcitriol—osteoporosis	0.00031	0.00117	CcSEcCtD
Trimethoprim—Skin disorder—Conjugated Estrogens—osteoporosis	0.00031	0.00117	CcSEcCtD
Trimethoprim—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000309	0.00117	CcSEcCtD
Trimethoprim—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000309	0.00117	CcSEcCtD
Trimethoprim—Dizziness—Raloxifene—osteoporosis	0.000309	0.00117	CcSEcCtD
Trimethoprim—Vomiting—Estropipate—osteoporosis	0.000307	0.00116	CcSEcCtD
Trimethoprim—Dizziness—Ibandronate—osteoporosis	0.000306	0.00115	CcSEcCtD
Trimethoprim—Rash—Estropipate—osteoporosis	0.000304	0.00115	CcSEcCtD
Trimethoprim—Dermatitis—Estropipate—osteoporosis	0.000304	0.00115	CcSEcCtD
Trimethoprim—Anorexia—Conjugated Estrogens—osteoporosis	0.000304	0.00115	CcSEcCtD
Trimethoprim—Urticaria—Risedronate—osteoporosis	0.000303	0.00114	CcSEcCtD
Trimethoprim—Headache—Estropipate—osteoporosis	0.000302	0.00114	CcSEcCtD
Trimethoprim—Vomiting—Alendronate—osteoporosis	0.000302	0.00114	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000302	0.00114	CcSEcCtD
Trimethoprim—Abdominal pain—Risedronate—osteoporosis	0.000302	0.00114	CcSEcCtD
Trimethoprim—Body temperature increased—Risedronate—osteoporosis	0.000302	0.00114	CcSEcCtD
Trimethoprim—Rash—Alendronate—osteoporosis	0.0003	0.00113	CcSEcCtD
Trimethoprim—Insomnia—Zoledronate—osteoporosis	0.0003	0.00113	CcSEcCtD
Trimethoprim—Dermatitis—Alendronate—osteoporosis	0.000299	0.00113	CcSEcCtD
Trimethoprim—Feeling abnormal—Pamidronate—osteoporosis	0.000299	0.00113	CcSEcCtD
Trimethoprim—Headache—Alendronate—osteoporosis	0.000298	0.00112	CcSEcCtD
Trimethoprim—Vomiting—Raloxifene—osteoporosis	0.000297	0.00112	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Pamidronate—osteoporosis	0.000296	0.00112	CcSEcCtD
Trimethoprim—Dyspnoea—Zoledronate—osteoporosis	0.000295	0.00111	CcSEcCtD
Trimethoprim—Rash—Raloxifene—osteoporosis	0.000295	0.00111	CcSEcCtD
Trimethoprim—Dermatitis—Raloxifene—osteoporosis	0.000294	0.00111	CcSEcCtD
Trimethoprim—Vomiting—Ibandronate—osteoporosis	0.000294	0.00111	CcSEcCtD
Trimethoprim—Tremor—Estradiol—osteoporosis	0.000293	0.0011	CcSEcCtD
Trimethoprim—Headache—Raloxifene—osteoporosis	0.000293	0.0011	CcSEcCtD
Trimethoprim—Rash—Ibandronate—osteoporosis	0.000292	0.0011	CcSEcCtD
Trimethoprim—Dermatitis—Ibandronate—osteoporosis	0.000292	0.0011	CcSEcCtD
Trimethoprim—Dyspepsia—Zoledronate—osteoporosis	0.000292	0.0011	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000291	0.0011	CcSEcCtD
Trimethoprim—Headache—Ibandronate—osteoporosis	0.00029	0.00109	CcSEcCtD
Trimethoprim—Insomnia—Conjugated Estrogens—osteoporosis	0.000288	0.00109	CcSEcCtD
Trimethoprim—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000288	0.00109	CcSEcCtD
Trimethoprim—Vomiting—Calcitriol—osteoporosis	0.000288	0.00109	CcSEcCtD
Trimethoprim—Decreased appetite—Zoledronate—osteoporosis	0.000288	0.00109	CcSEcCtD
Trimethoprim—Agitation—Estradiol—osteoporosis	0.000287	0.00108	CcSEcCtD
Trimethoprim—Nausea—Estropipate—osteoporosis	0.000287	0.00108	CcSEcCtD
Trimethoprim—Abdominal pain—Pamidronate—osteoporosis	0.000287	0.00108	CcSEcCtD
Trimethoprim—Body temperature increased—Pamidronate—osteoporosis	0.000287	0.00108	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000286	0.00108	CcSEcCtD
Trimethoprim—Angioedema—Estradiol—osteoporosis	0.000286	0.00108	CcSEcCtD
Trimethoprim—Rash—Calcitriol—osteoporosis	0.000286	0.00108	CcSEcCtD
Trimethoprim—Dermatitis—Calcitriol—osteoporosis	0.000285	0.00108	CcSEcCtD
Trimethoprim—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000284	0.00107	CcSEcCtD
Trimethoprim—Headache—Calcitriol—osteoporosis	0.000284	0.00107	CcSEcCtD
Trimethoprim—Constipation—Zoledronate—osteoporosis	0.000283	0.00107	CcSEcCtD
Trimethoprim—Nausea—Alendronate—osteoporosis	0.000282	0.00106	CcSEcCtD
Trimethoprim—Hypersensitivity—Risedronate—osteoporosis	0.000281	0.00106	CcSEcCtD
Trimethoprim—Vertigo—Estradiol—osteoporosis	0.000281	0.00106	CcSEcCtD
Trimethoprim—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000281	0.00106	CcSEcCtD
Trimethoprim—Syncope—Estradiol—osteoporosis	0.00028	0.00106	CcSEcCtD
Trimethoprim—Nausea—Raloxifene—osteoporosis	0.000278	0.00105	CcSEcCtD
Trimethoprim—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000277	0.00105	CcSEcCtD
Trimethoprim—Pruritus—Ethinyl Estradiol—osteoporosis	0.000277	0.00104	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000275	0.00104	CcSEcCtD
Trimethoprim—Nausea—Ibandronate—osteoporosis	0.000275	0.00104	CcSEcCtD
Trimethoprim—Loss of consciousness—Estradiol—osteoporosis	0.000275	0.00104	CcSEcCtD
Trimethoprim—Feeling abnormal—Zoledronate—osteoporosis	0.000273	0.00103	CcSEcCtD
Trimethoprim—Cough—Estradiol—osteoporosis	0.000273	0.00103	CcSEcCtD
Trimethoprim—Constipation—Conjugated Estrogens—osteoporosis	0.000273	0.00103	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Zoledronate—osteoporosis	0.000271	0.00102	CcSEcCtD
Trimethoprim—Pruritus—Risedronate—osteoporosis	0.00027	0.00102	CcSEcCtD
Trimethoprim—Nausea—Calcitriol—osteoporosis	0.000269	0.00101	CcSEcCtD
Trimethoprim—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000268	0.00101	CcSEcCtD
Trimethoprim—Hypersensitivity—Pamidronate—osteoporosis	0.000267	0.00101	CcSEcCtD
Trimethoprim—Myalgia—Estradiol—osteoporosis	0.000266	0.001	CcSEcCtD
Trimethoprim—Arthralgia—Estradiol—osteoporosis	0.000266	0.001	CcSEcCtD
Trimethoprim—Anxiety—Estradiol—osteoporosis	0.000265	0.001	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000264	0.000997	CcSEcCtD
Trimethoprim—Urticaria—Zoledronate—osteoporosis	0.000263	0.000992	CcSEcCtD
Trimethoprim—Abdominal pain—Zoledronate—osteoporosis	0.000262	0.000987	CcSEcCtD
Trimethoprim—Body temperature increased—Zoledronate—osteoporosis	0.000262	0.000987	CcSEcCtD
Trimethoprim—Diarrhoea—Risedronate—osteoporosis	0.000261	0.000984	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000261	0.000983	CcSEcCtD
Trimethoprim—Dizziness—Ethinyl Estradiol—osteoporosis	0.000259	0.000976	CcSEcCtD
Trimethoprim—Confusional state—Estradiol—osteoporosis	0.000257	0.000971	CcSEcCtD
Trimethoprim—Pruritus—Pamidronate—osteoporosis	0.000257	0.000967	CcSEcCtD
Trimethoprim—Anaphylactic shock—Estradiol—osteoporosis	0.000255	0.000963	CcSEcCtD
Trimethoprim—Urticaria—Conjugated Estrogens—osteoporosis	0.000253	0.000955	CcSEcCtD
Trimethoprim—Dizziness—Risedronate—osteoporosis	0.000252	0.000951	CcSEcCtD
Trimethoprim—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000252	0.000951	CcSEcCtD
Trimethoprim—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000252	0.000951	CcSEcCtD
Trimethoprim—Shock—Estradiol—osteoporosis	0.000251	0.000947	CcSEcCtD
Trimethoprim—Nervous system disorder—Estradiol—osteoporosis	0.00025	0.000944	CcSEcCtD
Trimethoprim—Vomiting—Ethinyl Estradiol—osteoporosis	0.000249	0.000938	CcSEcCtD
Trimethoprim—Diarrhoea—Pamidronate—osteoporosis	0.000248	0.000936	CcSEcCtD
Trimethoprim—Skin disorder—Estradiol—osteoporosis	0.000248	0.000935	CcSEcCtD
Trimethoprim—Rash—Ethinyl Estradiol—osteoporosis	0.000247	0.00093	CcSEcCtD
Trimethoprim—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000246	0.000929	CcSEcCtD
Trimethoprim—Headache—Ethinyl Estradiol—osteoporosis	0.000245	0.000924	CcSEcCtD
Trimethoprim—Hypersensitivity—Zoledronate—osteoporosis	0.000244	0.00092	CcSEcCtD
Trimethoprim—Vomiting—Risedronate—osteoporosis	0.000243	0.000915	CcSEcCtD
Trimethoprim—Rash—Risedronate—osteoporosis	0.00024	0.000907	CcSEcCtD
Trimethoprim—Dermatitis—Risedronate—osteoporosis	0.00024	0.000906	CcSEcCtD
Trimethoprim—Dizziness—Pamidronate—osteoporosis	0.00024	0.000904	CcSEcCtD
Trimethoprim—Headache—Risedronate—osteoporosis	0.000239	0.000901	CcSEcCtD
Trimethoprim—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000235	0.000886	CcSEcCtD
Trimethoprim—Pruritus—Zoledronate—osteoporosis	0.000234	0.000884	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000233	0.000877	CcSEcCtD
Trimethoprim—Nausea—Ethinyl Estradiol—osteoporosis	0.000232	0.000876	CcSEcCtD
Trimethoprim—Insomnia—Estradiol—osteoporosis	0.000231	0.000871	CcSEcCtD
Trimethoprim—Vomiting—Pamidronate—osteoporosis	0.000231	0.000869	CcSEcCtD
Trimethoprim—Rash—Pamidronate—osteoporosis	0.000229	0.000862	CcSEcCtD
Trimethoprim—Dermatitis—Pamidronate—osteoporosis	0.000228	0.000861	CcSEcCtD
Trimethoprim—Dyspnoea—Estradiol—osteoporosis	0.000228	0.000858	CcSEcCtD
Trimethoprim—Headache—Pamidronate—osteoporosis	0.000227	0.000857	CcSEcCtD
Trimethoprim—Diarrhoea—Zoledronate—osteoporosis	0.000227	0.000855	CcSEcCtD
Trimethoprim—Nausea—Risedronate—osteoporosis	0.000227	0.000854	CcSEcCtD
Trimethoprim—Pruritus—Conjugated Estrogens—osteoporosis	0.000226	0.000851	CcSEcCtD
Trimethoprim—Dyspepsia—Estradiol—osteoporosis	0.000225	0.000847	CcSEcCtD
Trimethoprim—Decreased appetite—Estradiol—osteoporosis	0.000222	0.000837	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Estradiol—osteoporosis	0.00022	0.000831	CcSEcCtD
Trimethoprim—Dizziness—Zoledronate—osteoporosis	0.000219	0.000826	CcSEcCtD
Trimethoprim—Constipation—Estradiol—osteoporosis	0.000218	0.000823	CcSEcCtD
Trimethoprim—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000218	0.000823	CcSEcCtD
Trimethoprim—Nausea—Pamidronate—osteoporosis	0.000215	0.000812	CcSEcCtD
Trimethoprim—Dizziness—Conjugated Estrogens—osteoporosis	0.000211	0.000795	CcSEcCtD
Trimethoprim—Vomiting—Zoledronate—osteoporosis	0.000211	0.000794	CcSEcCtD
Trimethoprim—Feeling abnormal—Estradiol—osteoporosis	0.00021	0.000793	CcSEcCtD
Trimethoprim—Rash—Zoledronate—osteoporosis	0.000209	0.000788	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Estradiol—osteoporosis	0.000209	0.000787	CcSEcCtD
Trimethoprim—Dermatitis—Zoledronate—osteoporosis	0.000209	0.000787	CcSEcCtD
Trimethoprim—Headache—Zoledronate—osteoporosis	0.000207	0.000782	CcSEcCtD
Trimethoprim—Vomiting—Conjugated Estrogens—osteoporosis	0.000203	0.000765	CcSEcCtD
Trimethoprim—Urticaria—Estradiol—osteoporosis	0.000203	0.000765	CcSEcCtD
Trimethoprim—Body temperature increased—Estradiol—osteoporosis	0.000202	0.000761	CcSEcCtD
Trimethoprim—Abdominal pain—Estradiol—osteoporosis	0.000202	0.000761	CcSEcCtD
Trimethoprim—Rash—Conjugated Estrogens—osteoporosis	0.000201	0.000758	CcSEcCtD
Trimethoprim—Dermatitis—Conjugated Estrogens—osteoporosis	0.000201	0.000758	CcSEcCtD
Trimethoprim—Headache—Conjugated Estrogens—osteoporosis	0.0002	0.000753	CcSEcCtD
Trimethoprim—Nausea—Zoledronate—osteoporosis	0.000197	0.000742	CcSEcCtD
Trimethoprim—Nausea—Conjugated Estrogens—osteoporosis	0.000189	0.000714	CcSEcCtD
Trimethoprim—Hypersensitivity—Estradiol—osteoporosis	0.000188	0.000709	CcSEcCtD
Trimethoprim—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000184	0.00297	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000183	0.00297	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000183	0.00297	CbGpPWpGaD
Trimethoprim—DHFR—Disease—GSN—osteoporosis	0.000182	0.00295	CbGpPWpGaD
Trimethoprim—Pruritus—Estradiol—osteoporosis	0.000181	0.000681	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.00018	0.00291	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GPD2—osteoporosis	0.000179	0.0029	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PGLS—osteoporosis	0.000179	0.0029	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000179	0.0029	CbGpPWpGaD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000177	0.00287	CbGpPWpGaD
Trimethoprim—Diarrhoea—Estradiol—osteoporosis	0.000175	0.000659	CcSEcCtD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000175	0.00283	CbGpPWpGaD
Trimethoprim—Dizziness—Estradiol—osteoporosis	0.000169	0.000637	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—MYC—osteoporosis	0.000167	0.0027	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PKM—osteoporosis	0.000165	0.00267	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—FDPS—osteoporosis	0.000165	0.00267	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ATIC—osteoporosis	0.000164	0.00266	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PNP—osteoporosis	0.000164	0.00266	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—PSMA2—osteoporosis	0.000164	0.00265	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—PSMA5—osteoporosis	0.000164	0.00265	CbGpPWpGaD
Trimethoprim—Vomiting—Estradiol—osteoporosis	0.000162	0.000612	CcSEcCtD
Trimethoprim—Rash—Estradiol—osteoporosis	0.000161	0.000607	CcSEcCtD
Trimethoprim—Dermatitis—Estradiol—osteoporosis	0.000161	0.000606	CcSEcCtD
Trimethoprim—Headache—Estradiol—osteoporosis	0.00016	0.000603	CcSEcCtD
Trimethoprim—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.00016	0.00259	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.00016	0.00259	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.00016	0.00259	CbGpPWpGaD
Trimethoprim—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000159	0.00258	CbGpPWpGaD
Trimethoprim—DHFR—Disease—LRP5—osteoporosis	0.000158	0.00257	CbGpPWpGaD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000158	0.00256	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000158	0.00255	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PGLS—osteoporosis	0.000156	0.00253	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GPD2—osteoporosis	0.000156	0.00253	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000155	0.00251	CbGpPWpGaD
Trimethoprim—Nausea—Estradiol—osteoporosis	0.000152	0.000572	CcSEcCtD
Trimethoprim—DHFR—Disease—LRP6—osteoporosis	0.000152	0.00245	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—MYC—osteoporosis	0.000146	0.00236	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RPL24—osteoporosis	0.000146	0.00236	CbGpPWpGaD
Trimethoprim—DHFR—Disease—LTF—osteoporosis	0.000146	0.00236	CbGpPWpGaD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000144	0.00233	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ATIC—osteoporosis	0.000143	0.00232	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PNP—osteoporosis	0.000143	0.00232	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—PSMA5—osteoporosis	0.000143	0.00231	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—PSMA2—osteoporosis	0.000143	0.00231	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000141	0.00228	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CA2—osteoporosis	0.000139	0.00226	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—OXCT1—osteoporosis	0.000139	0.00226	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—MGLL—osteoporosis	0.000136	0.0022	CbGpPWpGaD
Trimethoprim—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	0.000135	0.00219	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000131	0.00213	CbGpPWpGaD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000129	0.00208	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000128	0.00207	CbGpPWpGaD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000127	0.00205	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ACP5—osteoporosis	0.000126	0.00204	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000124	0.00202	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000123	0.00199	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CA2—osteoporosis	0.000122	0.00197	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—OXCT1—osteoporosis	0.000122	0.00197	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—MGLL—osteoporosis	0.000119	0.00192	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TPI1—osteoporosis	0.000117	0.0019	CbGpPWpGaD
Trimethoprim—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000117	0.0019	CbGpPWpGaD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000117	0.00189	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—IDH2—osteoporosis	0.000116	0.00187	CbGpPWpGaD
Trimethoprim—DHFR—Disease—P4HB—osteoporosis	0.00011	0.00179	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP27A1—osteoporosis	0.000109	0.00176	CbGpPWpGaD
Trimethoprim—DHFR—Disease—GAPDH—osteoporosis	0.000108	0.00175	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000107	0.00173	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ACP5—osteoporosis	0.000106	0.00171	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000105	0.00171	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000104	0.00169	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000104	0.00168	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	0.000103	0.00167	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NFATC1—osteoporosis	0.000103	0.00167	CbGpPWpGaD
Trimethoprim—DHFR—Disease—DKK1—osteoporosis	0.000102	0.00165	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	0.000102	0.00165	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000101	0.00164	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—IDH2—osteoporosis	0.000101	0.00163	CbGpPWpGaD
Trimethoprim—DHFR—Disease—WNT1—osteoporosis	9.83e-05	0.00159	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—TPI1—osteoporosis	9.83e-05	0.00159	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	9.68e-05	0.00157	CbGpPWpGaD
Trimethoprim—DHFR—Disease—FGA—osteoporosis	9.57e-05	0.00155	CbGpPWpGaD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.5e-05	0.00154	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP27A1—osteoporosis	9.48e-05	0.00154	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	9.43e-05	0.00153	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.3e-05	0.00151	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.28e-05	0.0015	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—P4HB—osteoporosis	9.24e-05	0.0015	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ACP5—osteoporosis	9.22e-05	0.00149	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	9.1e-05	0.00147	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GAPDH—osteoporosis	9.07e-05	0.00147	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—RAP1A—osteoporosis	8.83e-05	0.00143	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.67e-05	0.0014	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—TPI1—osteoporosis	8.57e-05	0.00139	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ENO1—osteoporosis	8.53e-05	0.00138	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	8.52e-05	0.00138	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PSMA2—osteoporosis	8.4e-05	0.00136	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PSMA5—osteoporosis	8.4e-05	0.00136	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	8.39e-05	0.00136	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	8.28e-05	0.00134	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—P4HB—osteoporosis	8.06e-05	0.00131	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GAPDH—osteoporosis	7.91e-05	0.00128	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	7.88e-05	0.00128	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CALCA—osteoporosis	7.83e-05	0.00127	CbGpPWpGaD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.73e-05	0.00125	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—RAP1A—osteoporosis	7.71e-05	0.00125	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	7.68e-05	0.00124	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	7.54e-05	0.00122	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL1B—osteoporosis	7.47e-05	0.00121	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.15e-05	0.00116	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ENO1—osteoporosis	7.14e-05	0.00116	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KL—osteoporosis	7.11e-05	0.00115	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PSMA5—osteoporosis	7.04e-05	0.00114	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PSMA2—osteoporosis	7.04e-05	0.00114	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—IL6—osteoporosis	6.71e-05	0.00109	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	6.41e-05	0.00104	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.26e-05	0.00101	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ENO1—osteoporosis	6.23e-05	0.00101	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—POMC—osteoporosis	6.2e-05	0.001	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PSMA2—osteoporosis	6.14e-05	0.000994	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PSMA5—osteoporosis	6.14e-05	0.000994	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	6.14e-05	0.000994	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PKM—osteoporosis	5.85e-05	0.000947	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FDPS—osteoporosis	5.85e-05	0.000947	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TGFB1—osteoporosis	5.8e-05	0.00094	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP19A1—osteoporosis	5.71e-05	0.000924	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ADCY5—osteoporosis	5.57e-05	0.000902	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPD2—osteoporosis	5.54e-05	0.000898	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PGLS—osteoporosis	5.54e-05	0.000898	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.54e-05	0.000897	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.52e-05	0.000894	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.46e-05	0.000884	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TNF—osteoporosis	5.42e-05	0.000878	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	5.22e-05	0.000845	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—osteoporosis	5.16e-05	0.000836	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MTHFR—osteoporosis	5.12e-05	0.000829	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PKM—osteoporosis	5.09e-05	0.000825	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FDPS—osteoporosis	5.09e-05	0.000825	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PNP—osteoporosis	5.07e-05	0.000821	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ATIC—osteoporosis	5.07e-05	0.000821	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—POMC—osteoporosis	5.05e-05	0.000817	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP19A1—osteoporosis	4.98e-05	0.000807	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IRS2—osteoporosis	4.87e-05	0.000789	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PGLS—osteoporosis	4.83e-05	0.000782	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPD2—osteoporosis	4.83e-05	0.000782	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.78e-05	0.000774	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PKM—osteoporosis	4.76e-05	0.000771	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FDPS—osteoporosis	4.76e-05	0.000771	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ADCY5—osteoporosis	4.66e-05	0.000755	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GPX1—osteoporosis	4.65e-05	0.000753	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—osteoporosis	4.62e-05	0.000747	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPD2—osteoporosis	4.51e-05	0.00073	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PGLS—osteoporosis	4.51e-05	0.00073	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	4.5e-05	0.000729	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ATIC—osteoporosis	4.42e-05	0.000715	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PNP—osteoporosis	4.42e-05	0.000715	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA2—osteoporosis	4.31e-05	0.000698	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—OXCT1—osteoporosis	4.31e-05	0.000698	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—MTHFR—osteoporosis	4.29e-05	0.000695	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IRS1—osteoporosis	4.25e-05	0.000689	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MGLL—osteoporosis	4.2e-05	0.00068	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ATIC—osteoporosis	4.13e-05	0.000668	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PNP—osteoporosis	4.13e-05	0.000668	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ADCY5—osteoporosis	4.07e-05	0.000659	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GPX1—osteoporosis	4.06e-05	0.000657	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—osteoporosis	4.03e-05	0.000652	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6R—osteoporosis	4e-05	0.000647	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.96e-05	0.000641	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—OXCT1—osteoporosis	3.76e-05	0.000608	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA2—osteoporosis	3.76e-05	0.000608	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—MTHFR—osteoporosis	3.74e-05	0.000606	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MGLL—osteoporosis	3.66e-05	0.000593	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—IDH2—osteoporosis	3.57e-05	0.000578	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—OXCT1—osteoporosis	3.51e-05	0.000568	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA2—osteoporosis	3.51e-05	0.000568	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—POMC—osteoporosis	3.43e-05	0.000556	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MGLL—osteoporosis	3.42e-05	0.000554	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP27A1—osteoporosis	3.36e-05	0.000544	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—POMC—osteoporosis	3.33e-05	0.000539	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ACP5—osteoporosis	3.27e-05	0.000529	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.23e-05	0.000522	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.22e-05	0.000522	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FDPS—osteoporosis	3.14e-05	0.000508	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PKM—osteoporosis	3.14e-05	0.000508	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—IDH2—osteoporosis	3.11e-05	0.000504	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TPI1—osteoporosis	3.04e-05	0.000492	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—POMC—osteoporosis	2.99e-05	0.000485	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PGLS—osteoporosis	2.97e-05	0.000482	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPD2—osteoporosis	2.97e-05	0.000482	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP27A1—osteoporosis	2.93e-05	0.000474	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—IDH2—osteoporosis	2.91e-05	0.000471	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.87e-05	0.000465	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.86e-05	0.000464	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—P4HB—osteoporosis	2.86e-05	0.000462	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ACP5—osteoporosis	2.85e-05	0.000461	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GAPDH—osteoporosis	2.8e-05	0.000454	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP27A1—osteoporosis	2.73e-05	0.000443	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—RAP1A—osteoporosis	2.73e-05	0.000442	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ATIC—osteoporosis	2.72e-05	0.000441	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PNP—osteoporosis	2.72e-05	0.000441	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.68e-05	0.000434	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.67e-05	0.000433	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ACP5—osteoporosis	2.66e-05	0.000431	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TPI1—osteoporosis	2.65e-05	0.000428	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.62e-05	0.000425	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—P4HB—osteoporosis	2.49e-05	0.000403	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TPI1—osteoporosis	2.47e-05	0.0004	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GAPDH—osteoporosis	2.44e-05	0.000395	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.38e-05	0.000385	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—RAP1A—osteoporosis	2.38e-05	0.000385	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—osteoporosis	2.37e-05	0.000383	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—osteoporosis	2.36e-05	0.000383	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—P4HB—osteoporosis	2.32e-05	0.000376	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA2—osteoporosis	2.31e-05	0.000375	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—OXCT1—osteoporosis	2.31e-05	0.000375	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GAPDH—osteoporosis	2.28e-05	0.000369	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MGLL—osteoporosis	2.25e-05	0.000365	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—RAP1A—osteoporosis	2.22e-05	0.00036	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ENO1—osteoporosis	2.21e-05	0.000357	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PSMA5—osteoporosis	2.17e-05	0.000352	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PSMA2—osteoporosis	2.17e-05	0.000352	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.94e-05	0.000314	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ENO1—osteoporosis	1.92e-05	0.000311	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH2—osteoporosis	1.92e-05	0.00031	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PSMA2—osteoporosis	1.89e-05	0.000307	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PSMA5—osteoporosis	1.89e-05	0.000307	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.8e-05	0.000292	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ENO1—osteoporosis	1.8e-05	0.000291	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—osteoporosis	1.78e-05	0.000288	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PSMA5—osteoporosis	1.77e-05	0.000287	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PSMA2—osteoporosis	1.77e-05	0.000287	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.76e-05	0.000286	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACP5—osteoporosis	1.75e-05	0.000284	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TPI1—osteoporosis	1.63e-05	0.000264	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP19A1—osteoporosis	1.54e-05	0.000249	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—P4HB—osteoporosis	1.53e-05	0.000248	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GAPDH—osteoporosis	1.5e-05	0.000244	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—RAP1A—osteoporosis	1.47e-05	0.000237	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ADCY5—osteoporosis	1.44e-05	0.000233	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPX1—osteoporosis	1.44e-05	0.000233	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.44e-05	0.000232	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—osteoporosis	1.33e-05	0.000215	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ADCY5—osteoporosis	1.26e-05	0.000203	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPX1—osteoporosis	1.25e-05	0.000203	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ENO1—osteoporosis	1.18e-05	0.000192	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ADCY5—osteoporosis	1.17e-05	0.00019	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPX1—osteoporosis	1.17e-05	0.000189	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PSMA5—osteoporosis	1.17e-05	0.000189	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PSMA2—osteoporosis	1.17e-05	0.000189	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—osteoporosis	1.15e-05	0.000187	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—osteoporosis	1.08e-05	0.000175	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—POMC—osteoporosis	1.06e-05	0.000172	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.47e-06	0.000153	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—POMC—osteoporosis	9.24e-06	0.00015	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—POMC—osteoporosis	8.63e-06	0.00014	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ADCY5—osteoporosis	7.74e-06	0.000125	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPX1—osteoporosis	7.71e-06	0.000125	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—osteoporosis	7.12e-06	0.000115	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—POMC—osteoporosis	5.69e-06	9.21e-05	CbGpPWpGaD
